Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Capital Work in Progress

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹238 Cr₹177 Cr₹181 Cr₹338 Cr₹188 Cr

What is the latest Capital Work in Progress ratio of GLAND PHARMA ?

The latest Capital Work in Progress ratio of GLAND PHARMA is ₹238 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹238 Cr
Mar2023₹177 Cr
Mar2022₹181 Cr
Mar2021₹338 Cr
Mar2020₹188 Cr

How is Capital Work in Progress of GLAND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2024 ₹238 Cr
34.23
Mar2023 ₹177 Cr
-1.95
Mar2022 ₹181 Cr
-46.49
Mar2021 ₹338 Cr
79.24
Mar2020 ₹188 Cr -

Compare Capital Work in Progress of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹33,882.1 Cr 1.9% 9.6% 3.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.5% 4.1% -0.8% Stock Analytics
DIVIS LABORATORIES ₹176,604.0 Cr 0.5% -2.9% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,316.0 Cr 6.2% 9.3% 17.9% Stock Analytics
CIPLA ₹125,993.0 Cr 4.9% 2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,795.0 Cr 2.1% 1.2% -5% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

1.9%

9.6%

3.7%

SENSEX

-1.5%

-2.5%

0.2%


You may also like the below Video Courses